Acasti Pharma reported $2.32M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Acasti Pharma USD 2.32M 349K Jun/2025
Addus HomeCare USD 151.38M 3.45M Jun/2025
Amarin USD 162.41M 17.54M Mar/2025
Cassava Sciences USD 47.33M 35.58M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Option Care Health USD 773.62M 59.96M Jun/2025
Organigram Holdings CAD 107.28M 38.32M Jun/2025
Tilray USD 278.52M 15.02M Nov/2024